Pyxis Oncology, Inc. (PYXS) Misses Q3 EPS by 1c

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q3 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Rain Enhancement Technologies signs fog-testing deal with CHP
• Hewlett Packard Enterprise (HPE) call put ratio 2.2 calls to 1 put into quarter results